13F HOLDINGS REPORT
FCPM III SERVICES B.V.
Quarter ended Q2 2024 · Filed August 8, 2024 · Accession 0001802806-24-000036
Total Value
$678.1M
Positions
11
Other Managers
2
Confidential Omitted
No
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DYNE THERAPEUTICS INC | DYN | 6,416,793 | $226.4M | 33.39% |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 6,635,391 | $127.5M | 18.80% |
| 3 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 5,196,070 | $99.8M | 14.72% |
| 4 | ENGENE HOLDINGS INC | ENGNW | 5,783,752 | $54.5M | 8.04% |
| 5 | DYNE THERAPEUTICS INC | DYN | 1,428,571 | $50.4M | 7.43% |
| 6 | REPLIMUNE GROUP INC | REPL | 4,866,449 | $43.8M | 6.46% |
| 7 | BICYCLE THERAPEUTICS PLC | BCYC | 2,122,892 | $43.0M | 6.34% |
| 8 | ENGENE HOLDINGS INC | ENGNW | 2,894,199 | $27.3M | 4.02% |
| 9 | ENGENE HOLDINGS INC | ENGNW | 2,403,072 | $2.9M | 0.42% |
| 10 | ACHILLES THERAPEUTICS PLC | 00449L102 | 2,390,050 | $1.9M | 0.29% |
| 11 | ENGENE HOLDINGS INC | ENGNW | 475,076 | $565,340 | 0.08% |